{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Bioptimal%20International","name":"Bioptimal International","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-11-13T14:38:21.503Z"},"count":1,"matches":[{"id":"87937e7b6a2d33fe","posted_date":"2024-05-07","letter_issue_date":"2024-04-03","company_name":"Bioptimal International","issuing_office":"\"OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality\"","subject":"CGMP/QSR/Medical Devices/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/87937e7b6a2d33fe"}]}